Correlation of 18F-FLT uptake with tumor grade and Ki-67 immunohistochemistry in patients with newly diagnosed and recurrent gliomas

Journal of Nuclear Medicine

Volumn 53, Issue 12, 2012, Pages 1911-1915

  Yamamoto, Yuka ^a   Ono, Yuko ^a   Aga, Fumitoshi ^a   Kawai, Nobuyuki ^a   Kudomi, Nobuyuki ^a   Nishiyama, Yoshihiro ^a  

^a KAGAWA UNIVERSITY   (Japan)

Author keywords

18F FLT; Glioma; PET; Proliferation

Indexed keywords

3' FLUOROTHYMIDINE F 18; KI 67 ANTIGEN; 2',3' DIDEOXYNUCLEOSIDE DERIVATIVE; 3' FLUOROTHYMIDINE; DIAGNOSTIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CHILD; CORRELATION ANALYSIS; DIAGNOSTIC IMAGING; FEMALE; GLIOMA; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECURRENT CANCER; RETROSPECTIVE STUDY; SCHOOL CHILD; TUMOR CLASSIFICATION; TUMOR GROWTH; BRAIN TUMOR; METABOLISM; MIDDLE AGED; PATHOLOGY; RECURRENT DISEASE; TRANSPORT AT THE CELLULAR LEVEL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL TRANSPORT; BRAIN NEOPLASMS; CHILD; DIDEOXYNUCLEOSIDES; FEMALE; GLIOMA; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; MIDDLE AGED; NEOPLASM GRADING; RECURRENCE; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84870310802     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.112.104729     Document Type: Article

References (20)

1. DeAngelis LM. Brain tumors. N Engl J Med. 2001;344:114-123. (Pubitemid 32052502)
2. 11C] methionine PET, histopathology, and survival in primary brain tumors and recurrence. Am J Neuroradiol. 2006;27:1432-1437.
3. 11C-methionine for PET guided stereotactic brain biopsy of gliomas. J Nucl Med. 2004;45:1293-1298.
4. Wong TZ, van der Westhuizen GJ, Coleman RE. Positron emission tomography imaging of brain tumors. Neuroimaging Clin N Am. 2002;12:615-626. (Pubitemid 36015495)
5. 18F-fluorothymidine (FLT) PET in patients with newly diagnosed glioma. Eur J Nucl Med Mol Imaging. 2008;35:2009-2017.
6. 11C-methylmethionine as markers of increased transport and proliferation in brain tumors. J Nucl Med. 2005;46:1948-1958.
7. 18F-FDG. J Nucl Med. 2005;46:945-952.
8. 18F]3′-deoxy-3′- fluorothymidine PET for the diagnosis and grading of brain tumors. Eur J Nucl Med Mol Imaging. 2005;32:653-659.
9. Yamamoto Y, Wong TZ, Turkington TG, et al. 3′-deoxy-3′-[F-18] fluorothymidine positron emission tomography in patients with recurrent glioblastoma multiforme: comparison with Gd-DTPA enhanced magnetic resonance imaging. Mol Imaging Biol. 2006;8:340-347. (Pubitemid 44741371)
10. Ullrich R, Backes H, Li H, et al. Glioma proliferation as assessed by 3′-fluoro-3′-deoxy-l-thymidine positron emission tomography in patients with newly diagnosed high-grade glioma. Clin Cancer Res. 2008;14:2049-2055. (Pubitemid 351551115)
11. Spence AM, Muzi M, Link JM, et al. NCI-sponsored trial for evaluation of safety and preliminary efficacy of 3′-deoxy-3′-[F-18]fluorothymidine (FLT) as a marker of proliferation in patients with recurrent gliomas: preliminary efficacy studies. Mol Imaging Biol. 2009;11:343-355.
12. 18F]fluorothymidine positron emission tomography: a pilot study. J Clin Oncol. 2007;25:4714-4721.
13. 18F-fluorothymidine during treatment monitoring of recurrent high-grade glioma. J Nucl Med. 2010;51:720-727.
14. Rasey JS, Grierson JR, Wiens LW, et al. Validation of FLT uptake as a measure of thymidine kinase-1 activity in A549 carcinoma cells. J Nucl Med. 2002;43:1210-1217. (Pubitemid 34988769)
15. Louis DN, Ohgaki H, Wiestler OD, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007;114:97-109. (Pubitemid 47103521)
16. 18F]FLT). J Radioanal Nucl Chem. 2000;24:843-846.
17. 18F]FLT: portrait of a proliferation marker. Eur J Nucl Med Mol Imaging. 2002;29:165-169.
18. 18F] FLT for imaging of cellular proliferation in vivo. Nucl Med Biol. 2000;27:143-156.
19. Cao Y, Tsien CI, Shen Z, et al. Use of magnetic resonance imaging to assess blood-brain/blood-gliomas barrier opening during conformal radiotherapy. J Clin Oncol. 2005;23:4127-4136. (Pubitemid 46211318)
20. Barwick T, Bencherif B, Mountz JM, Avril N. Molecular PET and PET/CT imaging tumour cell proliferation using F-18 fluoro-L-thymidine: a comprehensive evaluation. Nucl Med Commun. 2009;30:908-917.